SCHEMBL752253

SCHEMBL752253

Cc1cccc(C(I)(I)S(=O)(=O)C(I)(I)c2cccc(C)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.42
TSHR P16473 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
KIF11 P52732 5/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KCNH2 Q12809 1/20 0.38
PTPN5 P54829 1/20 0.37
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
ELANE P08246 1/20 0.35
PARP1 P09874 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24406055 0.74 ACHE (0.50) ACHELMNAKIF11CYP3A4CYP2D6
SCHEMBL753849 0.73 CA1 (0.43) TSHRKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL15255849 0.72 ACHE (0.48) ACHETSHRLMNAKMT2AKIF11
SCHEMBL17571915 0.72 ACHE (0.42) ACHELMNAKMT2AKIF11CYP3A4
SCHEMBL25908570 0.71 ACHE (0.46) ACHELMNAKMT2AKIF11CYP3A4
M-Xylene SCHEMBL27875113 0.71 ACHE (0.67) ACHETSHRLMNAKMT2AALDH1A1
SCHEMBL16551075 0.71 CDK1 (0.50) TSHRKMT2ACYP3A4CYP2C19PTPN5
SCHEMBL18378184 0.70 ACHE (0.50) ACHETSHRLMNAKIF11CYP3A4
SCHEMBL7039820 0.69 ACHE (0.44) ACHELMNAKMT2AKIF11CYP3A4
SCHEMBL17571919 0.69 LMNA (0.43) ACHELMNAKMT2AKIF11CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed